糖尿病的肌肉骨表现 - 一个更新
1Academic clinical fellow in Rheumatology (ST2), Rheumatology department, Royal London Hospital, London E1 4DG.
Clinical medicine (London, England)
|August 12, 2025
概括
糖尿病显著影响肌肉骨健康,影响超过一半的患者,并恶化糖尿病管理. 本综述更新了这些并发症及其治疗方法的知识.
科学领域:
- 内分泌学 在内分泌学.
- 类风湿病学 类风湿病学
- 代谢疾病 代谢疾病
背景情况:
- 糖尿病是一种日益严重的全球健康问题,预计到2050年将影响13亿.
- 肌肉骨并发症影响超过50%的糖尿病患者,导致严重的发病率和残疾.
- 与糖尿病相关的诸如炎症,降低的代谢和受损的血液供应等因素有助于骨,肌肉和关节问题.
研究的目的:
- 为提供糖尿病中肌肉骨表现的最新审查.
- 讨论这些并发症的当前治疗策略.
- 突出代谢综合征对糖尿病肌肉骨健康的影响.
主要方法:
- 2015年以来的文献综述和近期研究的综合.
- 对与糖尿病相关的肌肉骨疾病研究的分析.
- 对治疗干预和管理指南的审查.
主要成果:
- 糖尿病加剧慢性炎症,损害组织修复,并可能导致关节破坏.
- 代谢综合征增加了糖尿病患者肌肉骨并发症的风险和严重程度.
- 肌肉骨问题导致久坐不动的生活方式,对糖尿病控制产生负面影响.
结论:
- 肌肉骨并发症是糖尿病管理的一个主要问题,需要综合护理.
- 更新的治疗方法对于减轻残疾和改善生活质量至关重要.
- 需要进一步的研究才能充分理解和管理糖尿病和肌肉骨健康之间的复杂相互作用.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
91
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
91
Diabetes: Symptoms, Diagnosis, and Complications
692
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
692
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Management and Pharmacotherapy
374
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
374


